Cumberland Partners Ltd Sells 500 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Cumberland Partners Ltd trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.5% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,500 shares of the company’s stock after selling 500 shares during the quarter. Cumberland Partners Ltd’s holdings in HCA Healthcare were worth $1,423,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Capital World Investors grew its stake in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of HCA Healthcare during the second quarter valued at approximately $131,527,000. Darsana Capital Partners LP grew its position in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the period. Swedbank AB purchased a new position in shares of HCA Healthcare during the first quarter worth $95,882,000. Finally, TD Asset Management Inc raised its stake in shares of HCA Healthcare by 30.4% in the first quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock valued at $240,581,000 after acquiring an additional 168,093 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

NYSE:HCA traded down $3.76 during midday trading on Tuesday, hitting $354.23. 115,981 shares of the stock were exchanged, compared to its average volume of 1,173,215. HCA Healthcare, Inc. has a one year low of $229.28 and a one year high of $417.14. The company has a market capitalization of $89.73 billion, a price-to-earnings ratio of 16.08, a P/E/G ratio of 1.36 and a beta of 1.68. The business has a 50-day moving average price of $388.86 and a two-hundred day moving average price of $356.86. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. KeyCorp lowered their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. TD Cowen cut their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Finally, Leerink Partners boosted their price target on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.